Latest Content

In honor of Lung Cancer Awareness Month, CURE spoke with Dr. Daniel J. Boffa about how the understanding of lung cancer is evolving beyond smoking.

FOG-001 received fast track designation after early study results showed tumor shrinkage in all evaluable patients with desmoid tumors.

Following the 2025 ESMO Congress, Dr. Joshua Saba sat down with Dr. Chandler Park to discuss recent advances in prostate cancer care.

A woman shares how vision loss led to her cancer diagnosis and how lifestyle changes, support and community helped her regain control after her cancer had spread.

Cindy and Katie share how caring for parents with cholangiocarcinoma led to friendship, support and advocacy through the Cholangiocarcinoma Foundation.

The FDA approved Poherdy as the first interchangeable biosimilar to Perjeta for patients with HER2-positive breast cancer.

As a breast cancer survivor, I try to stay up to date on new ways to detect cancer early. When I first heard about a simple blood test called Cancerguard, I sat up a little straighter.

The FDA has granted orphan drug designation to tinostamustine, an investigational therapeutic, for the treatment of patients with malignant gliomas.

The FDA approved Komzifti in relapsed or refractory acute myeloid leukemia with a susceptible NPM1 mutation.

Leading oncology experts share emerging research and developments shaping the year ahead, from precision medicine to innovative cancer therapies.

After her own breast cancer treatment, Maureen advocated for legislation to make scalp cooling more accessible for patients seeking to preserve their hair.

For Maureen Green, scalp cooling was a crucial part of her breast cancer treatment journey, as it prevented chemotherapy-induced hair loss.

A survivor shares how hearing loss and cancer deepened her grief, leading her to confront denial and embrace support from her church community.